New Caledonia

Reimbursed Care Access

New Caledonia is a French sui generis collectivity with its own local health administration but drug control and medicines regulation are exercised under the framework of the French Public Health Code and national drug-scheduling decisions; therefore most classic psychedelics are treated the same as in mainland France (listed as stupéfiants) with no authorized medical use outside regulated pathways or clinical research. Esketamine (Spravato) has European marketing authorization and is hospital‑restricted in France and may be made available in New Caledonia through hospital supply/import procedures, while racemic ketamine remains a controlled hospital medicine used for anesthesia and occasionally administered off‑label for psychiatric indications (not routinely reimbursed for such off‑label use).